155 related articles for article (PubMed ID: 32698394)
1. Identification of Prognostic Markers in Patients with Primary Vitreoretinal Lymphoma by Clustering Analysis Using Clinical Data.
Tsubota K; Usui Y; Goto H
J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32698394
[TBL] [Abstract][Full Text] [Related]
2. Prognosis, Risk Factors, and Clinical Features of Intraocular Recurrence in Primary Vitreoretinal Lymphoma.
Liu S; Jiang T; Gu J; Zhou X; Chen W; Ping B; Zhou Y; Zhang T; Huang X; Xu G; Chang Q
Ophthalmol Retina; 2024 Apr; 8(4):317-324. PubMed ID: 37918656
[TBL] [Abstract][Full Text] [Related]
3. CD79B mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential.
Yonese I; Takase H; Yoshimori M; Onozawa E; Tsuzura A; Miki T; Mochizuki M; Miura O; Arai A
Eur J Haematol; 2019 Feb; 102(2):191-196. PubMed ID: 30390359
[TBL] [Abstract][Full Text] [Related]
4. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.
Chan CC; Rubenstein JL; Coupland SE; Davis JL; Harbour JW; Johnston PB; Cassoux N; Touitou V; Smith JR; Batchelor TT; Pulido JS
Oncologist; 2011; 16(11):1589-99. PubMed ID: 22045784
[TBL] [Abstract][Full Text] [Related]
5. Case 01-2017 - Primary vitreoretinal lymphoma (PVRL): report of a case and update of literature from 1942 to 2016.
Wang Y; Cheung DS; Chan CC
Ann Eye Sci; 2017 Jul; 2():. PubMed ID: 30167573
[TBL] [Abstract][Full Text] [Related]
6. Two cases of primary vitreoretinal lymphoma: a diagnostic challenge : The supporting role of multimodal imaging in the diagnosis of primary vitreoretinal lymphoma.
Morara M; Foschi F; Veronese C; Torrazza C; Bacci F; Stefoni V; Ciardella PA
Int Ophthalmol; 2018 Feb; 38(1):353-361. PubMed ID: 28039672
[TBL] [Abstract][Full Text] [Related]
7. Primary vitreoretinal lymphoma.
Kalogeropoulos D; Vartholomatos G; Mitra A; Elaraoud I; Ch'ng SW; Zikou A; Papoudou-Bai A; Moschos MM; Kanavaros P; Kalogeropoulos C
Saudi J Ophthalmol; 2019; 33(1):66-80. PubMed ID: 30930667
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling of primary vitreoretinal lymphoma.
Arai A; Takase H; Yoshimori M; Yamamoto K; Mochizuki M; Miura O
Cancer Sci; 2020 Apr; 111(4):1417-1421. PubMed ID: 32056332
[TBL] [Abstract][Full Text] [Related]
9. Recurrent pseudohypopyon in association with primary vitreoretinal lymphoma: a case report.
Kitao M; Hashida N; Nishida K
BMC Ophthalmol; 2016 Jul; 16():103. PubMed ID: 27391815
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostics and treatment of primary vitreoretinal lymphoma].
Stübiger N; Kakkassery V; Gundlach E; Winterhalter S; Pleyer U
Ophthalmologe; 2015 Mar; 112(3):223-30. PubMed ID: 25698590
[TBL] [Abstract][Full Text] [Related]
11. Recent progress in the diagnosis and treatment of primary vitreoretinal lymphoma.
Zhou M; Xu G
Taiwan J Ophthalmol; 2016; 6(4):170-176. PubMed ID: 29018736
[TBL] [Abstract][Full Text] [Related]
12. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018.
Castellino A; Pulido JS; Johnston PB; Ristow KM; Nora Bennani N; Inwards DJ; Macon WR; Micallef INM; King RL; Salomao DR; Witzig TE; Habermann TM; Nowakowski GS
Am J Hematol; 2019 Mar; 94(3):291-298. PubMed ID: 30516868
[TBL] [Abstract][Full Text] [Related]
13. Association of Disease Location and Treatment With Survival in Diffuse Large B-Cell Lymphoma of the Eye and Ocular Adnexal Region.
Ahmed AH; Foster CS; Shields CL
JAMA Ophthalmol; 2017 Oct; 135(10):1062-1068. PubMed ID: 28880986
[TBL] [Abstract][Full Text] [Related]
14. Primary vitreoretinal lymphoma: prevalence, impact, and management challenges.
Venkatesh R; Bavaharan B; Mahendradas P; Yadav NK
Clin Ophthalmol; 2019; 13():353-364. PubMed ID: 30858685
[TBL] [Abstract][Full Text] [Related]
15. Primary Vitreoretinal Lymphoma: A Retrospective Study of 20 Eyes.
Luo JY; Yu ST; Xu XY; Lin XX; Luo RJ; Long CD
J Ophthalmol; 2022; 2022():4522974. PubMed ID: 35814482
[TBL] [Abstract][Full Text] [Related]
16. Factors related to central nervous system involvement of primary vitreoretinal lymphoma.
Kim JY; Kim JJ; Kim RY; Kim M; Park YG; Park YH
Graefes Arch Clin Exp Ophthalmol; 2024 Mar; ():. PubMed ID: 38446203
[TBL] [Abstract][Full Text] [Related]
17. Central Nervous System Progression in Primary Vitreoretinal Lymphoma with Bilateral and Unilateral Involvement: A Systematic Review and Meta-Analysis.
van Rooij JLM; Tokarska KA; Ten Dam-van Loon NH; Wessels PH; Seute T; Minnema MC; Snijders TJ
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740632
[TBL] [Abstract][Full Text] [Related]
18. [Primary vitreoretinal lymphoma].
Jaehne D; Coupland SE
Ophthalmologe; 2018 Apr; 115(4):343-356. PubMed ID: 29589147
[TBL] [Abstract][Full Text] [Related]
19. Primary vitreoretinal lymphoma: an update on pathogenesis, diagnosis and treatment.
Reichstein D
Curr Opin Ophthalmol; 2016 May; 27(3):177-84. PubMed ID: 26859131
[TBL] [Abstract][Full Text] [Related]
20. Primary T-cell Vitreoretinal Non-Hodgkin Lymphoma: A Case Report and Literature Review.
Low A; Chow RC; Ee Ling A; Khaliddin N
Cureus; 2023 Jul; 15(7):e41341. PubMed ID: 37546106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]